FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308149697> ?p ?o ?g. }

• W4308149697 endingPage "3774" @default.
• W4308149697 startingPage "3740" @default.
• W4308149697 abstract "•We systematically describe the extensively accepted pyroptosis pathways •We summarize the advances and rationales of nanotechnologies in regulating pyroptosis •We expound on how/why lesion microenvironment engineering can regulate pyroptosis •We provide distinctive insights into the pyroptosis-engineered nanotechnologies Pyroptosis is closely associated with tumors and inflammatory diseases. By enhancing pyroptosis, direct and immune-response-triggered deaths of tumor cells are increased, while, by inhibiting pyroptosis, the progression of inflammatory diseases is alleviated. Nanomaterials and nanobiotechnologies are receiving increasing attention because of their unique advantages and diverse strategies, which hold great potential in treating pyroptosis-related diseases. In this review, we firstly describe the extensively accepted pyroptosis pathways and summarize pyroptosis inducers and inhibitors that may pose safety concerns. Subsequently, the advances and rationales of nanobiotechnology and therapeutic approaches in regulating pyroptosis for treating cancer and inflammation-associated diseases are summarized, where the activation or blockade of different pyroptosis pathways are highlighted and the correlation between pyroptosis and immunity is stressed. Also, we expound on how and why some abnormal components present in lesion microenvironment could be engineered after rationally different nanoplatforms. Finally, we provide distinctive insights into the pyroptosis-engineered nanobiotechnologies in tumor and inflammation disease treatments. Pyroptosis is closely associated with tumors and inflammatory diseases. By enhancing pyroptosis, direct and immune-response-triggered deaths of tumor cells are increased, while, by inhibiting pyroptosis, the progression of inflammatory diseases is alleviated. Nanomaterials and nanobiotechnologies are receiving increasing attention because of their unique advantages and diverse strategies, which hold great potential in treating pyroptosis-related diseases. In this review, we firstly describe the extensively accepted pyroptosis pathways and summarize pyroptosis inducers and inhibitors that may pose safety concerns. Subsequently, the advances and rationales of nanobiotechnology and therapeutic approaches in regulating pyroptosis for treating cancer and inflammation-associated diseases are summarized, where the activation or blockade of different pyroptosis pathways are highlighted and the correlation between pyroptosis and immunity is stressed. Also, we expound on how and why some abnormal components present in lesion microenvironment could be engineered after rationally different nanoplatforms. Finally, we provide distinctive insights into the pyroptosis-engineered nanobiotechnologies in tumor and inflammation disease treatments. Graphical Abstract View Large Image Figure Viewer Download Hi-res image" @default.
• W4308149697 created "2022-11-08" @default.
• W4308149697 creator A5030254997 @default.
• W4308149697 creator A5057290207 @default.
• W4308149697 creator A5086664284 @default.
• W4308149697 creator A5089760676 @default.
• W4308149697 date "2022-11-01" @default.
• W4308149697 modified "2023-09-30" @default.
• W4308149697 title "Emerging pyroptosis-engineered nanobiotechnologies regulate cancers and inflammatory diseases: A double-edged sword" @default.
• W4308149697 cites W1536607091 @default.
• W4308149697 cites W168035116 @default.
• W4308149697 cites W1864325817 @default.
• W4308149697 cites W1904683780 @default.
• W4308149697 cites W1953948364 @default.
• W4308149697 cites W1966079664 @default.
• W4308149697 cites W1967482791 @default.
• W4308149697 cites W1973404097 @default.
• W4308149697 cites W1974409640 @default.
• W4308149697 cites W1985538633 @default.
• W4308149697 cites W1989551786 @default.
• W4308149697 cites W1993442154 @default.
• W4308149697 cites W2007257062 @default.
• W4308149697 cites W2007636933 @default.
• W4308149697 cites W2018056701 @default.
• W4308149697 cites W2048497409 @default.
• W4308149697 cites W2052853635 @default.
• W4308149697 cites W2053908301 @default.
• W4308149697 cites W2068619092 @default.
• W4308149697 cites W2070454413 @default.
• W4308149697 cites W2071481518 @default.
• W4308149697 cites W2077730689 @default.
• W4308149697 cites W2088206187 @default.
• W4308149697 cites W2089503694 @default.
• W4308149697 cites W2091939066 @default.
• W4308149697 cites W2103966122 @default.
• W4308149697 cites W2105256361 @default.
• W4308149697 cites W2108269141 @default.
• W4308149697 cites W2111585885 @default.
• W4308149697 cites W2129144690 @default.
• W4308149697 cites W2130907138 @default.
• W4308149697 cites W2140109386 @default.
• W4308149697 cites W2149604935 @default.
• W4308149697 cites W2151566115 @default.
• W4308149697 cites W2166016039 @default.
• W4308149697 cites W2167957194 @default.
• W4308149697 cites W2218095309 @default.
• W4308149697 cites W2234115940 @default.
• W4308149697 cites W2292691093 @default.
• W4308149697 cites W2378121956 @default.
• W4308149697 cites W2396212074 @default.
• W4308149697 cites W2414773926 @default.
• W4308149697 cites W2418806051 @default.
• W4308149697 cites W2461915818 @default.
• W4308149697 cites W2462773201 @default.
• W4308149697 cites W2465658363 @default.
• W4308149697 cites W2496085280 @default.
• W4308149697 cites W2507143400 @default.
• W4308149697 cites W2518249323 @default.
• W4308149697 cites W2519942994 @default.
• W4308149697 cites W2529393815 @default.
• W4308149697 cites W2538503705 @default.
• W4308149697 cites W2560541542 @default.
• W4308149697 cites W2564122215 @default.
• W4308149697 cites W2573071355 @default.
• W4308149697 cites W2577569333 @default.
• W4308149697 cites W2586389563 @default.
• W4308149697 cites W2589187779 @default.
• W4308149697 cites W2604084092 @default.
• W4308149697 cites W2605484523 @default.
• W4308149697 cites W2608687752 @default.
• W4308149697 cites W2622554186 @default.
• W4308149697 cites W2728273616 @default.
• W4308149697 cites W2735172948 @default.
• W4308149697 cites W2755460304 @default.
• W4308149697 cites W2755796574 @default.
• W4308149697 cites W2757381139 @default.
• W4308149697 cites W2766031263 @default.
• W4308149697 cites W2770003411 @default.
• W4308149697 cites W2771968994 @default.
• W4308149697 cites W2779745123 @default.
• W4308149697 cites W2788640168 @default.
• W4308149697 cites W2792940053 @default.
• W4308149697 cites W2793830108 @default.
• W4308149697 cites W2795412955 @default.
• W4308149697 cites W2800992180 @default.
• W4308149697 cites W2805253918 @default.
• W4308149697 cites W2808365021 @default.
• W4308149697 cites W2883440571 @default.
• W4308149697 cites W2883734549 @default.
• W4308149697 cites W2895146907 @default.
• W4308149697 cites W2896767268 @default.
• W4308149697 cites W2899038975 @default.
• W4308149697 cites W2919321004 @default.
• W4308149697 cites W2921191934 @default.
• W4308149697 cites W2921778094 @default.
• W4308149697 cites W2939625028 @default.
• W4308149697 cites W2941850281 @default.
• W4308149697 cites W2945231757 @default.

• next